Mission
THE PHRMA FOUNDATION WORKS TO IMPROVE PUBLIC HEALTH BY PROACTIVELY INVESTING IN INNOVATIVE RESEARCH, EDUCATION AND VALUE-DRIVEN HEALTH CARE.
Public Charity
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FDN INC
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FDN INC is a nonprofit organization categorized as Public Charity based in WASHINGTON, DC. Its most recent IRS filing (2025) reports revenue of $4.9M, expenses of $5.2M, total assets of $28.8M. Imperigo tracks 4 reported grant relationships connected to this organization totaling approximately $537K.
EIN: 526063009
WASHINGTON, DC
Latest filing: 2025
Total Revenue$4.9M
Total Expenses$5.2M
Total Assets$28.8M
Grant Records4
Funding Total$537K
Filing Years2021–2025
Where $100 goes at Pharmaceutical Research and Manufacturers of America Fdn Inc
How Pharmaceutical Research and Manufacturers of America Fdn Inc divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$91
Programs
the work itself
$9
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $91 for programs
$26
Drug Discovery
$21
Drug Delivery
$18
Value Assessment-Health Outcomes Research (VA-HOR)
Plus 3 more programs. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL CONTRIBUTION
$160,585
General Contribution
$83,000
General Contribution
$100,000
GENERAL CONTRIBUTION
$193,020
Showing up to 5 of 4 total records — full history available with membership.
Officers & Directors
DIRECTOR (THRU 3/2025)
Aida Habtezion Md Msc Frcp
PRESIDENT
Amy Miller
CHAIRMAN
Andrew Plump Md Phd
DIRECTOR
Daniel Skovronsky Md Phd
Director
Donatello Crocetta
SENIOR DIRECTOR
Emily Ortman
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $4.9M | $5.2M | $28.8M |
| 2024 | $4.3M | $5.0M | $27.6M |
| 2023 | $4.2M | $4.4M | $24.5M |
| 2022 | $3.9M | $4.1M | $22.8M |
| 2021 | $3.7M | $4.4M | $26.2M |
Between 2021 and 2025, reported annual revenue grew from $3.7M to $4.9M (+33%), with total assets most recently reported at $28.8M.
Interactive year-over-year charts and full filing details available with membership.